insights_auto
Why is ORX up 4,71%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,89 SEK
arrow_upward
+4,71%(+0,040) 1D
17 ნოე, 15:33:32 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
312,63 მლნ.
Avg. vol.
790,03 ათ.
Volume
629,79 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
312,63 მლნ.
Avg. vol.
790,03 ათ.
Volume
629,79 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
16 წუთის წინ
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Investing.com
·
1 საათის წინ
Why Goldman Sachs expects the S&P 500 to rally in 2027
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com